AstraZeneca and thrombosis, lot suspended in Liguria as a precaution

After the rare cases of thrombosis following the administration of the AstraZenca vaccine, the Liguria health company Alisa, as a precaution, “instructed all vaccination sites to suspend, until further notice, the administration of batch ABX1506, if present. “. This is what is communicated in a note released by the institution. Read also “The reconnaissance is underway to verify any stock of the batch in question in the vaccination centers of Liguria”, informs Alisa. “As soon as the report of the two adverse reactions, which concern the two young women currently hospitalized at the San Martino Polyclinic, was received, the pharmacovigilance network was activated and the reports were promptly sent to the Italian drug agency Aifa; the lot concerned was therefore suspended as a precaution “.